Small Opioid Prescribing Change Will Have Big Impact

In the latest opioid prescribing change , hydrocodone has moved to Schedule II among controlled substances. In recognition of well-publicized reports that 99% of the worldwide supply of hydrocodone in 2007 was consumed in the United States,[1] the US Drug Enforcement Administration (DEA) enacted the Final Rule on October 6, 2014. More.*

*A Medscape account is required to view this article. If you do not have a Medscape account, you can create one for free.